Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00376987 · ClinicalTrials.gov registry record · Phase 2
Zinc Supplements in Lowering Cadmium Levels in Smokers
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT00376987 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 61 participants.
The verdict
NCT00376987, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
RATIONALE: Zinc supplements may lower cadmium levels in smokers and may help prevent DNA damage. PURPOSE: This clinical trial is studying how well zinc supplements work in lowering cadmium levels in smokers.
Interventions
- DIETARY_SUPPLEMENT zinc oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-12 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00376987
The ClinicalTrials.gov registry entry for NCT00376987 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which zinc oxide is the first listed.
NCT00376987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00376987 about?
NCT00376987 is a clinical study titled "Zinc Supplements in Lowering Cadmium Levels in Smokers". RATIONALE: Zinc supplements may lower cadmium levels in smokers and may help prevent DNA damage. PURPOSE: This clinical trial is studying how well zinc supplements work in lowering cadmium levels in smokers.
What is the current status of trial NCT00376987?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2003-12. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00376987?
The interventions under investigation include: zinc oxide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00376987?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.